These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 17909104)

  • 1. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
    Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
    Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular determinants and prognostic significance of CC Chemokine Ligand-18 (CCL18/PARC) in patients with stable coronary artery disease.
    De Sutter J; Struyf S; Van de Veire NR; Philippé J; De Buyzere M; Van Damme J
    J Mol Cell Cardiol; 2010 Nov; 49(5):894-6. PubMed ID: 20674579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events.
    de Jager SC; Kraaijeveld AO; Grauss RW; de Jager W; Liem SS; van der Hoeven BL; Prakken BJ; Putter H; van Berkel TJ; Atsma DE; Schalij MJ; Jukema JW; Biessen EA
    J Mol Cell Cardiol; 2008 Sep; 45(3):446-52. PubMed ID: 18619972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CC-chemokine ligand 18/pulmonary activation-regulated chemokine expression in the CNS with special reference to traumatic brain injuries and neoplastic disorders.
    Chang CY; Lee YH; Leu SJ; Wang CY; Wei CP; Hung KS; Pai MH; Tsai MD; Wu CH
    Neuroscience; 2010 Feb; 165(4):1233-43. PubMed ID: 19958819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice.
    Krohn R; Raffetseder U; Bot I; Zernecke A; Shagdarsuren E; Liehn EA; van Santbrink PJ; Nelson PJ; Biessen EA; Mertens PR; Weber C
    Circulation; 2007 Oct; 116(16):1812-20. PubMed ID: 17893273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of CC chemokine ligand 18 in extrinsic atopic dermatitis patients.
    Park CO; Lee HJ; Lee JH; Wu WH; Chang NS; Hua L; Lee MG; Lee KH
    Exp Dermatol; 2008 Jan; 17(1):24-9. PubMed ID: 17979978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
    Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
    Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus].
    Tao JH; Li XP; Li XM; Kan M; Zhai ZM; Wang W
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3051-4. PubMed ID: 17288835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis.
    Momohara S; Okamoto H; Iwamoto T; Mizumura T; Ikari K; Kawaguchi Y; Takeuchi M; Kamatani N; Tomatsu T
    J Rheumatol; 2007 Feb; 34(2):266-71. PubMed ID: 17304652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma chemokine CCL18/PARC in beta-thalassemia.
    Dimitriou E; Verhoek M; Altun S; Karabatsos F; Moraitou M; Youssef J; Boot R; Sarafidou J; Karagiorga M; Aerts H; Michelakakis H
    Blood Cells Mol Dis; 2005; 35(3):328-31. PubMed ID: 16137900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel monoclonal antibodies detect elevated levels of the chemokine CCL18/DC-CK1 in serum and body fluids in pathological conditions.
    van der Voort R; Kramer M; Lindhout E; Torensma R; Eleveld D; van Lieshout AW; Looman M; Ruers T; Radstake TR; Figdor CG; Adema GJ
    J Leukoc Biol; 2005 May; 77(5):739-47. PubMed ID: 15713699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
    Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
    Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice.
    Braunersreuther V; Pellieux C; Pelli G; Burger F; Steffens S; Montessuit C; Weber C; Proudfoot A; Mach F; Arnaud C
    J Mol Cell Cardiol; 2010 Apr; 48(4):789-98. PubMed ID: 19665464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes.
    de Jager SC; Bongaerts BW; Weber M; Kraaijeveld AO; Rousch M; Dimmeler S; van Dieijen-Visser MP; Cleutjens KB; Nelemans PJ; van Berkel TJ; Biessen EA
    PLoS One; 2012; 7(9):e45804. PubMed ID: 23029252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris.
    Inami N; Nomura S; Manabe K; Kimura Y; Iwasaka T
    Platelets; 2006 Dec; 17(8):565-70. PubMed ID: 17127484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF.
    Nomura S; Inami N; Kanazawa S; Iwasaka T; Fukuhara S
    Stem Cells; 2004; 22(5):696-703. PubMed ID: 15342934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of chemokines in exercise-induced bronchoconstriction in asthma.
    Tahan F; Karaaslan C; Aslan A; Kiper N; Kalayci O
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):819-25. PubMed ID: 16802769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
    Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets.
    Damås JK; Waehre T; Yndestad A; Otterdal K; Hognestad A; Solum NO; Gullestad L; Frøland SS; Aukrust P
    Circulation; 2003 Jun; 107(21):2670-6. PubMed ID: 12742982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients.
    Pawlak K; Mysliwiec M; Pawlak D
    Thromb Res; 2008; 122(3):328-35. PubMed ID: 18048089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.